TEST:

ONCO/Reveal™ Essential MPN Panel

This study demonstrates that oncoReveal MLH1 and MGMT Methylation Panel performed very well against comparator methods. The performance characteristics and workflow benefits are suitable for clinical testing.

This intra-laboratory study demonstrates that the oncoReveal Essential MPN Panel performed very well against comparator methods. The performance characteristics, workflow benefits, and TAT saving are suitable for clinical testing of MPN patient population to allow accurate clinical assessment.

The essential MPN high throughput panel is a robust and reproducible assay using blood, bone marrow and cell pellet. The molecular alterations detected by this assay can assist in diagnosis, prognosis and making cancer treatment decisions involving targeted therapies in a clinically relevant turn-around time.